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Background: In Chinese traditional medicine, Agrimonia pilosa Ledeb (APL) exhibits great effect on treatment of
type 2 diabetes mellitus (T2DM), however its mechanism is still unknown. Considering that T2DM are correlated
with postprandial hyperglycemia and oxidative stress, we investigated the α-glucosidase inhibitory activity and the
antioxidant activity of flavonoid compound (FC) and triterpenoid compound (TC) from APL.
Methods: Entire plants of APL were extracted using 95% ethanol and 50% ethanol successively. The resulting
extracts were partitioned and isolated by applying liquid chromatography using silica gel column and Sephadex LH
20 column to give FC and TC. The content of total flavonoids in FC and the content of total triterpenoids in TC
were determined by using UV spectrophotometry. HPLC analysis was used to identify and quantify the monomeric
compound in FC and TC. The α-glucosidase inhibitory activities were determined using the chromogenic method
with p-nitrophenyl-α-D-glucopyranoside as substrate. Antioxidant activities were assessed through three kinds of
radical scavenging assays (DPPH radical, ABTS radical and hydroxyl radical) & β-carotene-linoleic acid assay.
Results: The results indicate FC is abundant of quercitrin, and hyperoside, and TC is abundant of 1β, 2β, 3β,
19α-tetrahydroxy-12-en-28-oic acid (265.2 mg/g) and corosolic acid (100.9 mg/g). The FC & the TC have strong
α-glucosidase inhibitory activities with IC50 of 8.72 μg/mL and 3.67 μg/mL, respectively. We find that FC show
competitive inhibition against α-glucosidase, while the TC exhibits noncompetitive inhibition. Furthermore, The FC
exhibits significant radical scavenging activity with the EC50 values of 7.73 μg/mL, 3.64 μg/mL and 5.90 μg/mL on
DPPH radical, hydroxyl radical and ABTS radical, respectively. The FC also shows moderate anti-lipid peroxidation
activity with the IC50 values of 41.77 μg/mL on inhibiting β-carotene bleaching.
Conclusion: These results imply that the FC and the TC could be responsible for the good clinical effects of APL on
T2MD through targeting oxidative stress and postprandial hyperglycaemia. So APL may be good sources of natural
antioxidants and α-glucosidase inhibitors exhibiting remarkable potential value for the therapy of T2DM.
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Type II diabetes mellitus (T2DM) as an epidemic disease,
associated with increased significant social and financial
burden, is a cause of very high morbidity and mortal-
ity in the world [1]. It is well-known that the genesis
and progression of T2DM is generally attributed to sev-
eral factors including persistent hyperglycemia toxicity,
oxidative damage and lipotoxicity, etc. [1]. A widely held
notion is that postprandial hyperglycemia (PPHG) is a
primary risk factor in the development of T2DM and its
complications via multi-factorial mechanisms [2]. Mean-
while, increasing evidences suggest that oxidative stress
(OS) is involved in the pathogenesis of T2DM and the
development of diabetic complications through the mech-
anism of impairing oxidation reduction system, leading to
β-cell failure and insulin resistance [3,4].
Despite great efforts that have been made to normalize
blood glucose level in clinic practice, it is still a formidable
challenge. Even more difficult is the control of PPHG [5].
Nowadays, the more attentions are paid to control PPHG
based on the α-glucosidase, α-amylase, amylin analogues
as targets [6]. Among them, most therapeutic approaches
for controlling PPHG are the pharmacological inhibitors
with greatest effect on α-glucosidase including acorbose,
miglilol, emigitate, voglibiose, etc. [6,7]. However, the
continuous use of those synthetic agents should be limited
because those agents may cause side effects such as flatu-
lence, abdominal cramp, vomiting, and diarrhea [8,9].
Numerous studies have been carried out to screen natural
agents (active natural components and crude extracts) to
inhibit α-glucosidase activity without or with fewer side
effects [10]. On the other hand, overwhelming researches
suggest that natural antioxidants may be used to reduce
oxidative damage and decrease the occurrence of dia-
betic complications [11,12]. Therefore, it is a prospect-
ive strategy that PPHG and ROS are used as dual-target
to screen the natural drugs to combat the multiple dis-
orders of T2DM.
Agrimonia pilosa Ledeb (APL), a Chinese traditional
medicinal plant of Rosaceae family, is widely used to
treat blood, tumor, gastrointestinal, gynecological, geni-
tourinary diseases in Chinese traditional medicine [13].
Especially, in the past several decades Chinese trad-
itional medicine have shown the great effect of APL on
T2DM in clinical practice. But it is unclear how APL
acts on T2DM. Chemical composition studies reveal
that the APL is abounded with polyphenols, terpenoids
and coumarins etc. [14,15]. It has been reported that
some flavonoids and terpenoids from medicinal plants
have the inhibitory activities of α-glucosidase [16].
Moreover, the abundant flavonoids are mainly respon-
sible for the antioxidant activities of many herbs [17].
Therefore, we speculated that the APL could combat
T2DM through targeting PPHG and OS.In this study, we isolated the flavonoid compound
(FC) and the triterpenoid compound (TC) from APL,
and evaluated their α-glucosidase inhibition activity and
antioxidative activities. Meanwhile, the inhibitory effect
on α-glucosidase of the compounds with the different
ratio of the FC and the TC also was tested. Furthermore,
the inhibition kinetics against α-glucosidase of the FC
and the TC were studied.Methods
Chemicals
Butylated hydroxyl toluene (BHT), gallic acid, β-carotene,
linoleic acid, 1,1-diphenyl-2-picrylhydrazyl (DPPH·), ρ-ni-
trophenyl α-D-glucopyranoside(PNPG), 3,5-dinitro salicylic
acid, soluble potato starch and 1-deoxyrojirimycine, α-
Glucosidase (from Saccharomyces cerevisiae), HPLC
grade methanol and acetonitrile were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). Folin-Ciocalteu reagent
was obtained from E. Merck Co. (Darmstadt, Germany).
Standards including oleanolic acid, ursolic acid, vitexin, rutin,
hyperoside, luteolin-7-O-β-D-glucopyranoside, quercitrin,
quercetin, luteolin, apigenin and kaempferol were obtained
from the National Institutes for Food and Drug Control
(Beijing, China). 1β, 2β, 3β, 19α-tetrahydroxy-12-en-28-oic
acid, tormentic acid, maslinatic acid, corosolic acid and
tiliroside are isolated and identified by ourselves in lab. All
other reagents were analytical grade procured from indigen-
ous manufacturers.Plant materials and preparation of the extract
The dried entire plants of APL were purchased from
Western Medicine City (Chongqing, China) in 2011 and
verified by Changhua Wang (Chongqing Academy of
Chinese Materia Medica, China). Extracts were obtained
as follows: In brief, the dried entire plants (2 kg) were
chopped into small pieces (40 mesh) and soaked over-
night in 40 L of 95% ethanol, then was under refluxing
at 100°C for three times for 90 min, 90 min, 60 min,
respectively. The suspension was filtered to give solu-
tion A. Then the residue was extracted by 40 L of 50%
ethanol under refluxing as above condition to give solu-
tion B. The two filtrate solvents were evaporated in a
rotary vacuum evaporator at 45°C and then lyophilized to
give extract A and extract B. Then the extracts were sepa-
rated using liquid column chromatography (see Figure 1).
Finally, according to thin layer chromatography con-
trol with 10% sulfate in ethanol as color-developing
agent, Fr.A Ib2, Fr.A IIc and Fr.A IIb3 were mixed to
give triterpenoids compound (TC) and Fr.A Ic, Fr.A
Ib4, Fr.B IId, Fr.B IIe, Fr.B IIf, Fr.B IIg, and Fr.B IIh
were mixed to give flavonoid compound (FC). The TC
powder (2.5646 g) and the FC powder (9.5375 g) were
stored at 0–4°C.
Figure 1 The collected procedure of flavonoid compound (FC) and triterpenoid compounds (TC).
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Total flavonoids content in FC was determined by using
the aluminium chloride colorimetric method. A mixture
of 0.5 mL sample, 100 μL 10% aluminum chloride, 100 μL
1 M potassium acetate and 2.3 mL distilled water were
incubated at room temperature for 30 min. The absorb-
ance was measured at 415 nm. Quercetrin as a standard
was used to make the calibration curve. The estimation of
total flavonoids in the extracts was carried out in triplicate
and the results were averaged.
Determination of total triterpenoids content
Total triterpenoid content in TC was determined by using
UV spectrophotometry [18], with some modifications.
Reference substance (0.8 mL) was moved in 10 mL volu-
metric flask, to evaporate ethanol in water bath at 85°C and
then add 0.4 mL 5% vanillin-glacial acetic acid and 1.0 mL
perchloric acid, respectively. The mixture was kept in waterbath at 80°C for 20 min, cooled to room temperature in ice
bath, and 5.0 mL glacial acetic acid was added. The solu-
tions were mixed by manual shaking for 15–20 s and
allowed to stand for 15 min at room temperature. Finally,
the absorbance was measured at 765 nm. Ursolic as a
standard was used to make the calibration curve. The esti-
mation of total triterpenoid content in the extracts was car-
ried out in triplicate and the results were averaged.
HPLC analysis of flavonoids in FC
HPLC analysis was performed using Agilent1260 with
UV detector, and chromatographic separations were
conducted on a Welch ultimate XB-C18 column (4.6 ×
250 mm, 5 μm). The solvent system was a gradient of
mobile phase: soln. A: 0.1% phosphate in H2O; soln. B,
acetonitrile. The following gradient was used: 0–30 min,
87% A; 30–50 min, 87% A to 80% A; 50–70 min, 80% A
to 60% A; 70–80 min, 60% A to 87% A; 80-90 min,
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1.0 mL/min; column temp., 30°C; injection volume,
20 μL; UV detection at 350 nm.
HPLC analysis of triterpenoids in TC
HPLC analysis was performed using Agilent 1260 with UV
detector, and chromatographic separations were conducted
on a Welch ultimate XB-C18 column (4.6 × 250 mm,
5 μm). The solvent system was a gradient of mobile phase:
soln. A: 0.1% formic acid in H2O; soln. B: acetonitrile
and methnol (2:1, v/v). The following gradient was used:
0–10 min, 25% A; 10–15 min, 25% A to 30% A; 15–30 min,
30%A. Operating conditions were as follows: flowrate,
1.0 mL/min; column temp., 30°C; injection volume, 20 μL;
UV detection at 210 nm.
Inhibition assay for α-glucosidase activity
The α-glucosidase inhibitory activities of TC and the
FC were determined according to the chromogenic
method with slight modifications [19]. The substrate
solution p-nitrophenyl-α-D-glucopyranoside (pNPG,
Sigma Chemical Company) was prepared with 0.2 M of
Na-phosphate buffer (pH 6.8). The reaction mixture
contained 10 μL of 0.02 U/μL α-glucosidase solution in
0.2 M Na-phosphate buffer (pH6.8), 10 μL of a sample
in DMSO (or DMSO itself as blank control) with the con-
centration of 20.0, 50.0, 100.0, 200.0, 400.0, 500.0 μg/mL,
respectively, 50 μL of Na-phosphate buffer (pH6.8), which
were mixed and incubated at 37°C for 20 min. Then,
50 μL of 0.02 M PNPG was added, and the mixture was
incubated at 37°C for another 30 min. Finally, the reaction
was stopped by the addition of 100 μL 0.2 M Na2CO3
solutions. Amount of the p-nitrophenol released from
PNP-glycoside was quantified on a 96 microplate spectro-
photometer (Bio-Rad, USA) at 405 nm. The inhibitory rate
of sample on α-glucosidase was calculated by the following
formula.
Inhibition %ð Þ ¼ Ablank− Asample−Abackground
  
=Ablank  100:
All the tests were run in triplicate. The IC50 values
(concentration required to inhibit 50% enzyme activity)
were calculated by applying logarithmic regression ana-
lysis from the mean inhibitory values.
Kinetics of inhibition against α-glucosidase
Inhibition mode of the APL against α-glucosidase activ-
ities was measured with the increasing concentration of
p-nitrophenyl-α-D-glucopyranoside as a substrate in the
absence or presence of FC or TC at different concentra-
tions. Inhibition type was determined by Lineweaver-
Burk plot analysis of the data, which was calculated from
the result according to Michaelis-Menten kinetics.1,1-Diphenyl-2-picrylhydrazyl radical scavenging activity
Assay for the scavenging of stable free radical 1,1-diphe-
nyl-2-picrylhydrazyl (DPPH) was carried out as reported
earlier with some modifications [20]. Briefly, 100 μL sam-
ple in methanol was mixed with 1.9 mL of 0.1 mM DPPH
in ethanol. The concentration of the tested samples in the
mixture was 0.25, 0.5, 2.5, 5.0, 25.0, 50.0, 100.0 μg/mL,
respectively. The reaction mixture was shaken well and
incubated in dark at 37°C for 30 min and the absorbance
was measured at 517 nm. The blanks contained all the
reaction reagents except the extract or positive control
substances. BHT was used as positive control. The per-
centage scavenging values were calculated from the
absorbance of the blank (A0) and of the sample (AS) using
the following equation:
DPPH radicals scavenging activity %ð Þ
¼ 1–AS=A0ð Þ  100
Where AS was the absorbance of the sample and A0
was the absorbance of the blank (without sample).
Hydroxyl radical scavenging activity
The hydroxyl radical-scavenging assay was carried out
using the method described by De Avellar and Jin with
minor modifications [21]. 0.75 mM 1,10-phenanthroline
and 0.75 mM FeSO4 were prepared in 0.05 M phosphate
buffer (pH 7.4) and mixed thoroughly. 100 μL of sample
in methanol at different concentration of 5.0, 10.0, 50.0,
100.0, 500.0, 1000.0, 2000.0 μg/mL respectively, and
880 μL of above solution (incubated at 37°C for 30 min)
was dispensed to test tubes and 20 μL of H2O2 (0.01%)
were added. The reaction mixture was incubated in dark
at 37°C for 60 min, and measured at 536 nm. The
hydroxyl radical scavenging activities were calculated
using the following equation:
Hydroxyl radical scavenging activity %ð Þ
¼ AS–Acð Þ= A0–Acð Þ½   100
Where AS, absorbance of the sample; Ac, absorbance
of control solution containing 1,10-phenanthroline, FeSO4
and H2O2 without sample; A0, absorbance of blank solu-
tion containing 1,10-phenanthroline and FeSO4 without
H2O2 and sample.
ABTS radical scavenging assay
ABTS radical-scavenging activity was measured by modify-
ing the method described by Re et al. [22]. ABTS was
dissolved in de-ionized water to 7 mM concentration, and
potassium persulphate was added to a concentration of
2.45 mM (final concentration). After well mixed, the reac-
tion mixture was left to stand at room temperature over-
night (12–16 h) in the dark before usage (Fresh stocks
of ABTS solution were prepared every five days due to
Table 1 The contents of flavonoids in flavonoid
compound (FC)
Compounds Contents (mg/g)
Vitexin 24.2 ± 1.2
Rutin 10.8 ± 0.4
Hyperoside 9.8 ± 0.5
Luteolin-7-O-β-D-glucopyranoside 8.4 ± 0.8
Quercitrin 73.6 ± 2.6
Quercetin 13.9 ± 0.8
Tiliroside 31.2 ± 0.9
Luteolin 14.7 ± 1.1
Apigenin 11.3 ± 0.4
Kaempferol 2.7 ± 0.5
Note: Each value represents the mean ± S.D. (n = 3).
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at different concentrations of 1.25, 2.5, 12.5, 25.0, 125.0,
250.0, 500.0 μg/mL respectively was mixed with 0.3 mL
ABTS∙+ solution and 0.5 mL distill water. The mixture was
allowed to stand at room temperature for 2 min, and
the absorbance at 745 nm was immediately recorded.
Ascorbic acid served as a positive control. All the tests
were performed in triplicate and the graph was plotted
with the mean values. The assay was first carried out
on the percentage of inhibition which calculated by the
following formula:
ABTS radical−scavenging activity %ð Þ
¼ 1−As=Acð Þ  100
Where Ac was the absorbance of the blank (without
sample) and As was the absorbance of the sample.
Determination of the antilipid peroxidation activity with
the β-carotene bleaching assay
The anti-lipid peroxidation activity of the sample was
evaluated using β-carotene–linoleic acid model system
[23,24]. 1 mL β-carotene (0.2 mg/mL) in chloroform was
pipetted into a round-bottom flask (50 ml) containing
25 μL linoleic acid and 200 mg Tween-40. After the
mixture was evaporated to remove chloroform under
vacuum, 100 mL of distilled water saturated with oxygen
was added by vigorous shaking to form an emulsion.
2400 μL of this emulsion was added into 100 μL of the
sample in methanol with different concentrations. As
soon as the mixture was added to each tube, the zero
time absorbance was measured at 470 nm (AS
0). The
emulsion system was incubated for 2 h at 50°C (AS
t). A
blank without β-carotene was prepared for background
subtraction (Ac). BHT was used as a positive control.
The test was carried out in triplicate. Results were calcu-
lated using the following equation:






   100
Statistical analysis
All tests were performed in triplicate. Results were
expressed as the means ± SD (n = 3). The IC50 values
were calculated from linear regression analysis. A
paired-samples T test was used for the difference ana-
lysis between groups by using SPSS 19.0 software. Differ-
ence with a value of p < 0.01 were considered statistically
significant.
Results and discussion
Despite a great of efforts have been made in treatment of
T2DM in clinic, poor effect accounted for a single target
is still a major challenge. More and more researchessuggested that the multi-target therapy combining with
the control of postprandial hyperglycaemia and oxidative
stress may become a promising therapy strategy because
oxidative stress is mainly induced by postprandial hyper-
glycaemia [4]. There is increasing interest in screening of
bioactive compounds from herbal plant with the ability to
delay or prevent glucose absorption, and to reduce oxida-
tive damage. APL, as Chinese traditional medicine, has
been used to treat T2DM clinically for several decades, but
its pharmaco-mechanism is not so clear. To address the
mechanism at least to some degree, both α-glucosidase
inhibiting activity and antioxidant activity of the FC and the
TC from APL were studied. Many traditionally medicinal
plants and natural products have been tested for their
inhibition of α-glucosidase activities and anti-diabetic
potential [10], but few researches about APL have been
reported.
Based on the theory of the active components alignment,
the FC and the TC were isolated from APL. The total flavo-
noids content in FC is 316.53 ± 6.37 mg/g by using the
aluminum chloride colorimetric method with quercetrin as
a standard (y = 0.01718c – 0.00556, R2 =0.9994; x was the
concentration of the extract while y was the absorbance of
the flavonoids). By HPLC analysis, 10 flavonoids were iden-
tified and quantified: vitexin, rutin, hyperoside, luteolin-7-
O-β-D-glucopyranoside, quercitrin, quercetin, tiliroside,
luteolin, apigenin and kaempferol (Table 1). Chromato-
graphic profiles of flavonoids composition of FC are shown
in Figure 2. We found that quercitrin, tiliroside and vitexin
are abundant flavonoids which make up 64.3% of the 10
flavonoids.
The total triterpenoids content in TC is 415.97 ±
5.15 mg/g with ursolic as a standard (y = 0.05584x –
0.06093, R2 = 0.99949; x was the concentration of extract
while y was the absorbance of triterpenoids). And 6 triter-
penoids were identified and quantified by using HPLC
analysis: 1β, 2β, 3β, 19α-tetrahydroxy-12-en-28-oic acid,
Figure 2 HPLC chromatogram of flavonoid compositions in flavonoid compound (FC). (A) standard flavonoids; (B) FC. Peaks: 1: vitexin;
2: rutin; 3: hyperoside; 4: luteolin-7-O-β-D-glucopyranoside; 5: quercitrin; 6: quercetin; 7: tiliroside; 8: luteolin; 9: apigenin; 10: kaempferol.
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acid and ursolic acid (Table 2). Chromatographic profiles
of triterpenoids composition of TC are shown in Figure 3.
1β, 2β, 3β, 19α-tetrahydroxy-12-en-28-oic acid is the most
predominant triterpenoid in TC, contributing 265.2 mg/g.
The followings are corosolic acid (100.9 mg/g), maslinatic
acid (53.7 mg/g), ursolic acid (28.2 mg/g), tormentic acid
(22.2 mg/g), oleanolic acid (6.7 mg/g). The contents of
these six triterpenoids in TC add up to 476.9 mg/g.
α-glucosidase inhibition activity
Most importantly therapeutic approaches for decreasing
PPHG were to prevent absorption of glucose by inhibition
of α-glucosidase. So the inhibitory effects of the FC and
the TC from APL against α-glucosidase were studied
(Figure 4). And the IC50 (50% inhibitory concentration)
values were analyzed by SPSS software. Both the FC and
the TC could inhibit the activity of α-glucosidase in a
dose-dependent manner at the concentrations of 1.67–
41.67 μg/mL. The maximum inhibition is found to be
94.5% and 87.5% at the 41.67 μg/mL of the FC and the TC,
respectively. Compared with the FC (IC50 = 8.72 μg/mL),Table 2 The contents of triterpenoids in triterpenoid
compounds (TC)
Compounds Contents (mg/g)
Oleanolic acid 6.7 ± 0.4
Ursolic acid 28.2 ± 0.4
Maslinatic acid 53.7 ± 0.5
Corosolic acid 100.9 ± 7.5
Tormentic acid 22.2 ± 1.7
1β, 2β, 3β, 19α-tetrahydroxy-12-en-28-oic acid 265.2 ± 2.0
Note: Each value represents the mean ± S.D. (n = 3).the TC exhibits the stronger efficiency with the IC50 of
3.67 μg/mL. The activities of three complexes with mass
ratio of FC and TC as 4:1, 1:1 and 1:4 were also
determined. The data in Figure 5 show that the complex
with the mass ratio of FC and TC as 4:1 exhibits the best
inhibition activity against α-glucosidase among these three
complexes. The IC50 values of three complexes with mass
ratio of FC and TC as 4:1, 1:1 and 1:4 are 3.92, 10.39
and 9.39 μg/mL, respectively. Furthermore, the studies of
enzyme kinetics (see Figure 6) demonstrated that the FC
exhibits competitive inhibition against α-glucosidase, while
TC exhibits noncompetitive inhibition.
Previously some plant extracts have been reported to
inhibit α-glucosidase activity, such as the ethanol exract
of Andrographis paniculata (IC50 = 17.20 mg/mL) [25],
the ethanol extracts of Mangifera indica bark (IC50 =
314 μg/mL) [26], and the butanol extract of Acosmium
panamense (IC50 = 109 μg/mL) [27]. Compared with
these reported natural extracts, the FC and the TC from
APL showed excellent α-glucosidase inhibitory activities.
In addition, some natural products could exhibit differ-
ent inhibition modes against α-glucosidase, such as the
methanol fraction of Bitter melon in an uncompetitive
manner with an IC50 value of 2.60 mg/mL [28]. Our
results also show that the FC and the TC from APL
inhibit α-glucosidase in different modes, i.e. the FC in
competitive mode and the TC in noncompetitive inhib-
ition mode. In addition, it was reported that corosolic
acid from Lagerstroemia apeciosa leaves exhibit a
nocompetitive mode with an IC50 value of 3.53 μg/mL
[29]. And corosolic acid with the content of 100.9 mg/g
also is the second abundant triterpenoid in the TC
(Table 2). Furthermore, the inhibition activities against
α-glucosidase of the complexes with different mass ratio
Figure 3 HPLC chromatogram of triterpenoid compositions in triterpenoid compound (TC). (A) standard triterpenoids; (B) TC. Peaks: 1: 1β,
2β, 3β, 19α-tetrahydroxy-12-en-28-oic acid; 2: tormentic acid; 3: maslinatic acid; 4: corosolic acid; 5: oleanolic acid; 6: ursolic acid.
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inhibitory modes. The result reveals that the combin-
ation with mass ratio of FC and TC as 4:1 has superior-
ity inhibition activity against α-glucosidase to the other
complexes with mass ratio of FC and TC as 1:4 and 1:1
at the concentration range of 4.17- 33.33 μg/mL. But
when the concentration is greater than 33.33 μg/mL, the
complexes (FC: TC = 1:4, g/g) has better α-glucosidase
inhibition activity than others. Based on the results men-
tioned above, we could propose that, at the low concen-
tration, the competitive inhibition is dominant, but the
noncompetitive inhibition has a little advantage at the high
concentration. So we think that the APL has a potential
treating effect on T2MD, which is attributed partly to theFigure 4 Inhibitory activities of flavonoid compound (FC) and
triterpenoid compound (TC) from Agrimonia pilosa Ledeb.
against α-glucosidase.α-glucosidase inhibition activities of the FC and the TC for
the control of the postprandial hyperglycaemia.
In vitro antioxidant activity
In order to obtain the credible conclusion, four assays
including DPPH scavenging assay, hydroxyl radical
scavenging assay, ABTS radical scavenging assay and
β-carotene-linoleic acid assay were employed to evalu-
ate antioxidant activities of the FC and the TC.
The free radical scavenging activities of the FC and
the TC were evaluated using DPPH scavenging assay,
hydroxyl radical scavenging assay and ABTS radical
scavenging assay. As shown in Figures 7, 8 and 9, the FC
has significant radical scavenging activity in a dose-Figure 5 Inhibitory activities of the three complexes of
flavonoid compound (FC) and triterpenoid compound (TC) with
mass ratio of 4:1, 1:1 and 1:4 against α-glucosidase.
Figure 6 Lineweaver-Burk plot for the inhibition mode of flavonoid compound (FC) and triterpenoid compound (TC) against
α-glucosidase. No inhibitor: absence of sample as a control; TC1: 8ug/mL; TC2: 16ug/mL; FC1: 8ug/mL; FC2: 16ug/mL.
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EC50 values of the FC on DPPH radical, hydroxyl rad-
ical and ABTS radical are 7.7 μg/mL, 3.6 μg/mL and
5.9 μg/mL, respectively (Table 3). The EC50 values of
BHT which was used as positive control on DPPH radical
and hydroxyl radical are 7.7 μg/mL and 3.1 μg/mL, re-
spectively. And the EC50 values of the ascorbic acid used
as positive control on ABTS is 2.5 μg/mL. Compared with
the FC, the TC has weaker radical scavenging activity with
EC50 values on DPPH radical, hydroxyl radical and ABTS
radical of >100.0 μg/mL, 35.2 μg/mL and >100.0 μg/mL,
respectively (Table 3).0.25 0.50 2.50 5.00 25.00 50.00 100.00
Figure 7 DPPH radical scavenging activities of flavonoid
compound (FC) and triterpenoid compound (TC). Each value
represents the mean ± S.D. (n = 3).The anti-lipid peroxidation activity of the FC and the TC
were determined by using the β-carotene-linoleic acid sys-
tem and the results were shown in Figure 10. All of the
tested samples have inhibition activity on lipid peroxidation
in a dose-dependent manner (0.2 μg/mL-80.0 μg/mL). BHT
shows an excellent inhibitory activity (IC50 = 1.8 μg/mL),
while the IC50 values of the FC and the TC are 41.8 μg/mL
and 98.5 μg/mL, respectively. It is demonstrated that FC
has moderate anti-lipid peroxidation activity.
Among the quantified 10 flavonoids in FC, 6 flavo-
noids including quercetin, luteolin, rutin, hyperoside,
luteolin-7-O-β-D-glucopyranoside and quercitrin haveFigure 8 OH radical scavenging activities of flavonoid
compound (FC) and triterpenoid compound (TC). Each value
represents the mean ± S.D. (n = 3).
Figure 9 ABTS radical scavenging activities of flavonoid
compound (FC) and triterpenoid compound (TC). Each value
represents the mean ± S.D. (n = 3).
Figure 10 Anti-lipid peroxidation activities in the β-Carotene-
linoleic acid system of flavonoid compound (FC) and triterpen-
oid compound (TC) from Agrimonia pilosa Ledeb. Each value
represents the mean ± S.D. (n = 3).
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o-catechol group (3′, 4′–OH) in B ring [30]. These 6
flavonoids making up 65.4% of the quantified 10 flavo-
noids could be responsible for the FC’s significant
scavenging activities on DPPH radical, hydroxyl rad-
ical and ABTS radical. Radicals induced by postpran-
dial hyperglycaemia or other reasons [4,31], such as
superoxide anion radical and hydroxyl radical, have
the very high reactivity which enables them to react
with a wide range of molecules, such as protein, lipids,
and nucleotides leading to occurrence and develop-
ment of a variety of diseases including T2DM [3,32].
The remarkable scavenging activities of the FC on radical
imply that the FC could be responsible for the good clinical
effects of APL on T2MD targeting oxidative stress.
Conclusions
In conclusion, our findings suggest that the FC and the
TC could be responsible for the good clinical effects ofTable 3 The EC50 values and IC50 values of flavonoid
compound (FC) and triterpenoid compounds (TC) from
agrimonia pilosa ledeb




FC 7.7 ± 0.4 3.6 ± 0.2 5.9 ± 0.4* 41.8 ± 1.0*
TC >100.0 35.2 ± 0.3* >100.0 98.5 ± 1.2*
BHT 7.7 ± 0.2 3.1 ± 0.1 - 1.8 ± 0.2
Ascorbicacid - - 2.5 ± 0.1 -
Note: An asterisk (*) indicates a significant difference at the p < 0.01 level vs
positive control.
Each value represents the mean ± S.D. (n = 3).APL on T2MD through targeting oxidative stress and
postprandial hyperglycaemia. So APL may be good
sources of natural antioxidants and α-glucosidase inhibi-
tors exhibiting remarkable potential application in the
therapy of T2DM. Further investigations should be taken
to illustrate the pharmaco-mechanism deeply and to iso-
late the active components.Competing interests
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